Abstract Selecting the optimal biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) for patients with rheumatoid arthritis remains challenging. We developed and externally validated a causal inference framework combining double machine learning-based causal forests with guideline-derived safety constraints.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile